ArticlePloS one2016

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.

Ignacio Ortea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.